Phenylephrine Hydrochloride Market Size

  • Report ID: 6907
  • Published Date: Jan 02, 2025
  • Report Format: PDF, PPT

Phenylephrine Hydrochloride Market Size

Phenylephrine Hydrochloride Market size was USD 905.3 million in 2024 and is estimated to reach USD 2.4 billion by the end of 2037, expanding at a CAGR of 7.9% during the forecast period, i.e., 2025-2037. In 2025, the industry size of phenylephrine hydrochloride is evaluated at USD 976.8 million.  

The phenylephrine hydrochloride market is expanding due to the growing prevalence of seasonal allergies such as nasal congestion, sinusitis, common cold, and allergies. According to the National Institutes of Health (NIIH), one of the most prevalent chronic illnesses in the world, chronic rhinosinusitis (CRS) affects people of all ages. The estimated incidence rates in the USA, Europe, and China are 12.3%, 10.9%, and 13%, respectively. A basic component of the pharmaceutical business, phenylephrine HCL is an essential constituent in many prescription and over-the-counter drugs used to treat nasal congestion. Additionally, the phenylephrine hydrochloride market gains from phenylephrine HCL's versatility in various forms, such as liquids, oral pills, and nasal sprays.

 


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 6907
  • Published Date: Jan 02, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of phenylephrine hydrochloride was over USD 905.3 million.

The market size for phenylephrine hydrochloride is projected to cross USD 2.4 billion by the end of 2037 expanding at a CAGR of 7.9% during the forecast period i.e., between 2025-2037.

The major players in the market are Aarti Pharmalabs Limited, SNA Healthcare Private Limited, Shenzhen Oriental Pharmaceutical Co., Ltd., Unichem Laboratories Ltd., Transo-Pharm Handels GmbH, Hikma Pharmaceuticals PLC, Eton Pharmaceuticals, Inc., LGM Pharma, AstraZeneca plc, Abbott Laboratories, and others.

The nasal decongestion segment is anticipated to garner a share/size of 95.3% during 2025-2037.

The North America phenylephrine hydrochloride sector is poised to hold a 39.7% share by the end of 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample